Palantir Slides, Vertex Pharmaceuticals Surges, DoorDash Lower Despite Earnings Beat
On this episode of Stock Movers:- Palantir (PLTR) shares slide by the most in nearly a year after its financial results and projections failed to live up to investors’ lofty expectations. The company described rising demand for artificial intelligence software as a “ravenous whirlwind” and bumped its 2025 revenue forecast on Monday to about $3.9 billion from about $3.75 billion. - Vertex Pharmaceuticals (VRTX) shares fall after the company reported adjusted earnings per share for the first quarter that missed expectations. Analysts are mixed about the launch of the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.